Vise Technologies Inc. Buys Shares of 19,739 Acadia Healthcare Company, Inc. $ACHC

Vise Technologies Inc. purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 19,739 shares of the company’s stock, valued at approximately $583,000.

Several other institutional investors and hedge funds have also recently modified their holdings of ACHC. EverSource Wealth Advisors LLC increased its position in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Global Retirement Partners LLC purchased a new stake in shares of Acadia Healthcare in the 2nd quarter valued at approximately $68,000. Caitong International Asset Management Co. Ltd grew its stake in shares of Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after buying an additional 5,203 shares during the period. Finally, Parallel Advisors LLC increased its holdings in shares of Acadia Healthcare by 857.8% during the 1st quarter. Parallel Advisors LLC now owns 6,858 shares of the company’s stock worth $160,000 after buying an additional 6,142 shares during the last quarter.

Wall Street Analyst Weigh In

ACHC has been the topic of a number of recent analyst reports. Guggenheim upped their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 30th. TD Cowen lifted their target price on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. UBS Group upped their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, Royal Bank Of Canada raised their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $28.72 on Tuesday. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The company has a 50 day moving average price of $30.04 and a 200 day moving average price of $25.69. The stock has a market capitalization of $2.67 billion, a P/E ratio of -2.31, a PEG ratio of 9.01 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. During the same period in the prior year, the firm earned $0.83 earnings per share. The firm’s revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.